Research Week 2021 features more than 180 presentations, small “Beyond the bench” meetings with scientists in non-traditional professions, showcases and symposia and more — including four fantastic keynote speakers. All this takes place May 3-6, 2021. See the emerging details at ohsu.edu/research-week.
Student’s Choice Keynote: Striving for just systems
Monday, May 3, noon
Kelsey Priest, as a health systems researcher, has focused on addiction issues throughout her master’s in public health and Ph.D. studies. A 2020 STAT Wunderkind, she was referred to as one of “a new wave of addiction experts willing to throw out the rule book to save lives.” During her time in medical school, she co-founded OHSU’s Women’s Leadership Development Program, the OHSU Gender Equity Center, and was a trainer and facilitator for the Relational Leadership Institute.
Research Week Keynote
Tuesday, May 4, noon
Mike Lauer is the deputy director for Extramural Research at the National Institutes of Health, where he serves as the principal scientific leader and adviser to the director of the NIH on all matters relating to the substance, quality and effectiveness of the NIH extramural research program and administration. He has received numerous awards, including the NIH Equal Employment Opportunity Award of the Year and the Arthur S. Flemming Award for Exceptional Federal Service, in recognition of his efforts to grow a culture of learning and accountability.
Brain Awareness Lecture
Wednesday, May 5, noon
Kelly Monk is a senior scientist and co-director of the Vollum Institute. She is recognized for her breakthroughs in identifying the role of adhesion G protein-coupled receptors (aGPCRs) in the development, maintenance and regeneration of myelin, the protective sheath that surrounds many nerve cells. Monk joined the Vollum Institute in 2017 and was named director of the Vollum/OHSU Neuroscience Graduate Program in 2018.
Innovation, Health Equity, Policy Lecture
Thursday, May 6, 10 a.m.
McMurry-Heath’s career focus has been on broadening access to scientific progress so more patients from diverse backgrounds can benefit from cutting-edge innovation. She has worked with non-governmental organizations and think tanks, the private sector and government. The Obama-Biden transition team tapped her to conduct a comprehensive analysis of the NSF’s policies, programs and personnel. President Obama then named her associate science director of the FDA’s Center for Devices and Radiological Health under Commissioner Peggy Hamburg.